Additionally, in diabetic retinopathy, mTORC1 contributes to retinal damage, suggesting that targeting mTOR could be a therapeutic approach for retinal diseases like AMD (Liu et al. 2020). This evidence concerns the gene MTOR and age-related macular degeneration.